Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2018
Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor MicroenvironmentTakuya Kato, Kazuhiro Noma, Toshiaki Ohara, et al.
Breast Cancer Research and Treatment|January 25, 2015
Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cellsKyoko Shimoyama, Shunsuke Kagawa, Michihiro Ishida, et al.
Anticancer Research|December 30, 2025
Near-infrared Photoimmunotherapy Targeting High-risk Human Neuroblastoma Cells Expressing GD2Hiroshi Nouso, Hiroshi Tazawa, Terutaka Tanimoto, et al.
Cancer Letters|October 16, 2020
Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasisHiroki Kajioka, Shunsuke Kagawa, Atene Ito, et al.
BJS Open|January 19, 2024
Epidural versus patient-controlled intravenous analgesia on pain relief and recovery after laparoscopic gastrectomy for gastric cancer: randomized clinical trialSatoru Kikuchi, Takashi Matsusaki, Toshiharu Mitsuhashi, et al.
International Journal of Molecular Medicine|October 20, 2004
Stable long-term induction of perforin-positive CD8+ T cells in gut by oral administration of streptococcal preparation OK-432Norifumi Mino, Yoshio Naomoto, Yasuhiro Shirakawa, et al.
World Journal of Gastroenterology|December 17, 2009
Progress in researches about focal adhesion kinase in gastrointestinal tractHui-Fang Hao, Yoshio Naomoto, Xiao-Hong Bao, et al.
Surgery Today|May 29, 2021
Accreditation as a qualified surgeon improves surgical outcomes in laparoscopic distal gastrectomySatoru Kikuchi, Tetsuya Kagawa, Shinji Kuroda, et al.
Cancers|June 10, 2023
Conventional Cancer Therapies Can Accelerate Malignant Potential of Cancer Cells by Activating Cancer-Associated Fibroblasts in Esophageal Cancer ModelsSatoshi Komoto, Kazuhiro Noma, Takuya Kato, et al.
International Journal of Cancer|March 4, 2021
Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancerToru Narusaka, Toshiaki Ohara, Kazuhiro Noma, et al.
Pageof 15